Related Experiment Video
Updated: Jul 19, 2026

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
Interferon therapy for ocular disease
Friederike Mackensen1, Regina Max, Matthias D Becker
1Department of Ophthalmology, Interdisciplinary Uveitis Center, University of Heidelberg, Germany.
Purpose Of Review:
Interferons were first known for their antiviral action. Immunomodulatory therapy with interferons has been studied in various diseases. This paper summarizes the role and presumed mechanisms of action of type 1 interferons in the treatment of ocular disease.
Recent Findings:
Preliminary data show beneficial effects of interferons in ocular disease such as Behçet disease and multiple sclerosis-associated uveitis in terms of visual acuity, intraocular inflammation activity, and chronic macular edema. Another mode of application is topical as an adjuvant treatment in viral keratitis or ocular surface malignancies.
Summary:
Interferons are gaining a place in the treatment of ocular disease. Evidence is growing of their potential in ocular Behçet disease and multiple sclerosis-associated uveitis. Randomized, controlled clinical trials are needed to confirm this observation. Further insights into the complex mechanisms of action of interferons in health and disease will increase understanding of their mechanisms of action as a therapeutic substance.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy
Ophthalmic Drug Delivery Systems
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
